Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J-P Spano

Showing results (41-50 of 62) with videos related to

Pageof 7
Sort By:
British Journal of Cancer|September 3, 2009
CA 19-9 as a biomarker in advanced pancreatic cancer patients randomised to gemcitabine plus axitinib or gemcitabine aloneH S Wasan, G M Springett, C Chodkiewicz, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|February 5, 2015
[Global brain metastases management strategy: a multidisciplinary-based approach]P Métellus, A Tallet, F Dhermain, et al.
Bulletin Du Cancer|January 21, 2010
Coexpression of biological key modulators in primary colorectal carcinomas and related metastatic sites: implications for treatment with cetuximabA Barbier, J Domont, N Magné, et al.
Critical Reviews in Oncology/Hematology|April 11, 2008
Cetuximab efficacy and safety in a retrospective cohort of elderly patients with heavily pretreated metastatic colorectal cancerM Bouchahda, T Macarulla, J P Spano, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 22, 2006
Expression of chemokine receptors predicts the site of metastatic relapse in patients with axillary node positive primary breast cancerF Andre, N Cabioglu, H Assi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 25, 2021
High seroconversion rate but low antibody titers after two injections of BNT162b2 (Pfizer-BioNTech) vaccine in patients treated with chemotherapy for solid cancersR Palich, M Veyri, A Vozy, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 23, 2004
Chemokine receptor CXCR4 and early-stage non-small cell lung cancer: pattern of expression and correlation with outcomeJ-P Spano, F Andre, L Morat, et al.
Cancer Biomarkers : Section a of Disease Markers|May 27, 2008
Identification of a functional EGF-R/p60c-src/STAT3 pathway in colorectal carcinoma: analysis of its long-term prognostic valueA Tadlaoui Hbibi, C Lagorce, P Wind, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 18, 2008
Epidermal growth factor receptor (EGFR) status and K-Ras mutations in colorectal cancerG Milano, M-C Etienne-Grimaldi, L Dahan, et al.
HIV Medicine|January 30, 2019
Invasive cervical cancer in HIV-infected women: risk and survival relative to those of the general population in France. Results from the French Hospital Database on HIV (FHDH)-Agence Nationale de Recherches sur le SIDA et les Hépatites Virales (ANRS) CO4 cohort studyS Grabar, M Hleyhel, A Belot, et al.
Pageof 7

Showing results (41-50 of 62) with videos related to

Sort By:
Pageof 7
British Journal of Cancer|September 3, 2009
CA 19-9 as a biomarker in advanced pancreatic cancer patients randomised to gemcitabine plus axitinib or gemcitabine aloneH S Wasan, G M Springett, C Chodkiewicz, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|February 5, 2015
[Global brain metastases management strategy: a multidisciplinary-based approach]P Métellus, A Tallet, F Dhermain, et al.
Bulletin Du Cancer|January 21, 2010
Coexpression of biological key modulators in primary colorectal carcinomas and related metastatic sites: implications for treatment with cetuximabA Barbier, J Domont, N Magné, et al.
Critical Reviews in Oncology/Hematology|April 11, 2008
Cetuximab efficacy and safety in a retrospective cohort of elderly patients with heavily pretreated metastatic colorectal cancerM Bouchahda, T Macarulla, J P Spano, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 22, 2006
Expression of chemokine receptors predicts the site of metastatic relapse in patients with axillary node positive primary breast cancerF Andre, N Cabioglu, H Assi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 25, 2021
High seroconversion rate but low antibody titers after two injections of BNT162b2 (Pfizer-BioNTech) vaccine in patients treated with chemotherapy for solid cancersR Palich, M Veyri, A Vozy, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 23, 2004
Chemokine receptor CXCR4 and early-stage non-small cell lung cancer: pattern of expression and correlation with outcomeJ-P Spano, F Andre, L Morat, et al.
Cancer Biomarkers : Section a of Disease Markers|May 27, 2008
Identification of a functional EGF-R/p60c-src/STAT3 pathway in colorectal carcinoma: analysis of its long-term prognostic valueA Tadlaoui Hbibi, C Lagorce, P Wind, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 18, 2008
Epidermal growth factor receptor (EGFR) status and K-Ras mutations in colorectal cancerG Milano, M-C Etienne-Grimaldi, L Dahan, et al.
HIV Medicine|January 30, 2019
Invasive cervical cancer in HIV-infected women: risk and survival relative to those of the general population in France. Results from the French Hospital Database on HIV (FHDH)-Agence Nationale de Recherches sur le SIDA et les Hépatites Virales (ANRS) CO4 cohort studyS Grabar, M Hleyhel, A Belot, et al.
Pageof 7